FDA Recalls QUAD-MIX Injectable for Sterility Assurance Failure
Carolina Infusion recalls QUAD-MIX injectable (Lot 08082022@3) nationwide due to lack of sterility assurance, a critical safety requirement for injectable medications.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II classification without reported hospitalizations or illnesses. Sterility assurance failure in injectable medications represents a high-risk product defect with potential for serious infection, meeting the rubric criterion for 'risk-of-harm products where injury has not yet been reported.'
Plain-English summary
Carolina Infusion LLC is recalling QUAD-MIX 30MG/3MG/60MCG/0.2 Injectable due to a lack of assurance of sterility. The affected lot is 08082022@3, with a beyond-use date of October 7, 2022. The product was distributed nationwide in the United States.
QUAD-MIX is a prescription-only injectable medication. Sterility assurance is required for all injectable medications to prevent infections and serious health complications. This recall addresses a failure to ensure the affected lot meets required sterility standards.
The recalled product
- Product
- QUAD-MIX 30MG/3MG/60MCG/0.2 Injectable, 10 ML vial, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936.
- Manufacturer
- Carolina Infusion
- Category
- Drug — Injectable
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 08082022@3
- BUD: 10/07/2022
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 20 recalled by Carolina Infusion under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 20 products in this recall →Related recalls
Same manufacturer · Carolina Infusion
See all →- HighInjectable drug product recalled for lack of sterility assurance
FDA (Drugs) · 2022-09-21
- HighInjectable Steroid Product Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2022-09-21
- HighInjectable testosterone product recalled for sterility assurance defect
FDA (Drugs) · 2022-09-21
- HighInjectable Medication TRI-MIX Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2022-09-21
- HighSermorelin Acetate Injectable Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2022-09-21
Same hazard · sterility failure
See all →- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereTransvenous Pacing Electrode Tray with Bipolar Balloon Pacing Electrode Recalled
FDA (Devices) · 2026-07-22
- SevereArterial Line Kit with Lidocaine HCL Injection Fails Sterility Testing
FDA (Devices) · 2026-07-22
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22